Drug breakthrough could benefit those with common breast cancer

Treating patients who have a common form of breast cancer with immunotherapy, as well as chemotherapy, before and after surgery could be effective...

Related Keywords

United Kingdom ,Belgium ,Brussels ,Bruxelles Capitale ,Barcelona ,Comunidad Autonoma De Cataluna ,Spain ,Milan ,Lombardia ,Italy ,Institut Jules Bordet ,Javier Cortes ,Simon Vincent ,Michail Ignatiadis ,National Institute ,International Breast Cancer Centre ,Cancer Research United Kingdom ,Professor Javier Cortes ,Care Excellence ,Breast Cancer Now ,European Breast Cancer Conference ,Professor Michail Ignatiadis ,